Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation - Quiz - MDSpire

Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation

  • By

  • Fan Wang

  • Jiaxuan Zhao

  • Tongcun Zhang

  • Jiangzhou Shi

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation

  • by Fan Wang, Jiaxuan Zhao, Tongcun Zhang, Jiangzhou Shi

  • June 9, 2026

Related Content

Tislelizumab combined with gemcitabine as first-line treatment in cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma: a single center, single-arm phase 2 trial

Dual concatenated transfer learning with attention fusion: An ensemble-enhanced approach for skin lesion classification

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement